Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help increase the UK's share of the global pharmaceutical research and development market.

The Department, alongside the former Department of Business, Energy and Industrial Strategy, have jointly commissioned an independent review of clinical trials. The review, currently underway, will offer recommendations on how commercial clinical trials can help the life sciences sector unlock United Kingdom growth and investment opportunities. It will also advise on how to resolve key challenges in conducting commercial clinical trials in the UK and will build on the 2021 publication of ‘Saving and Improving Lives: The Future of UK Clinical Research Delivery’. This vision sets out plans restructuring the UK’s research delivery to enable increased recruitment and market share of global trial numbers and aims to make study set-up and delivery faster, more efficient and more innovative. All of these measures will offer the assurance to global pharmaceutical companies that the UK remains one of the best places in the world to deliver cutting-edge research and increase the share of the global pharmaceutical research and development market.